1. ScholarBank@NUS

Alan Prem Kumar

rp02898

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Alan Prem Kumar
Variants
Kumar, A.P.
Kumar, A.
Prem Kumar, A.
Kumar, Alan Prem Rem
 
Main Affiliation
 
Faculty
 
Email
apkumar@nus.edu.sg
 
Other emails
 

Publications

Refined By:
Department:  DEAN'S OFFICE (MEDICINE)
Subject:  Science & Technology

Results 21-35 of 35 (Search time: 0.014 seconds).

Issue DateTitleAuthor(s)
211-Oct-2021Mindfulness Awareness Practice (MAP) to Prevent Dementia in Older Adults with Mild Cognitive Impairment: Protocol of a Randomized Controlled Trial and Implementation OutcomesNg, Ted Kheng Siang; Feng, Lei ; Fam, Johnson ; Rawtaer, Iris ; Kumar, Alan Prem ; Rane, Grishma ; Cheah, Irwin Kee-Mun ; Mahendran, Ratha ; Lee, Yuan Kun ; Tan, Ene Choo ; Goh, Lee Gan ; Kua, Ee Heok ; Mahendran, Rathi 
21-Jan-2018Molecular targets and anti-cancer potential of escinCheong, Dorothy HJ ; Arfuso, Frank; Sethi, Gautam ; Wang, Lingzhi ; Hui, Kam Man ; Kumar, Alan Prem ; Thai, Tran 
31-Sep-2021Multi-target weapons: diaryl-pyrazoline thiazolidinediones simultaneously targeting VEGFR-2 and HDAC cancer hallmarksUpadhyay, Neha; Tilekar, Kalpana; Safuan, Sabreena; Kumar, Alan P ; Schweipert, Markus; Meyer-Almes, Franz-Josef; Ramaa, CS
417-Jun-2022(Nano)platforms in bladder cancer therapy: Challenges and opportunitiesAshrafizadeh, Milad; Zarrabi, Ali; Karimi-Maleh, Hassan; Taheriazam, Afshin; Mirzaei, Sepideh; Hashemi, Mehrdad; Hushmandi, Kiavash; Makvandi, Pooyan; Nazarzadeh Zare, Ehsan; Sharifi, Esmaeel; Goel, Arul; Wang, Lingzhi ; Ren, Jun; Nuri Ertas, Yavuz; Kumar, Alan Prem ; Wang, Yuzhuo; Rabiee, Navid; Sethi, Gautam ; Ma, Zhaowu
511-Dec-2020Pharmacological Inhibition of BAD Ser99 Phosphorylation Enhances the Efficacy of Cisplatin in Ovarian Cancer by Inhibition of Cancer Stem Cell-like BehaviorWang, Yanxin; Chiou, Yi-Shiou; Chong, Qing-Yun ; Zhang, Mengyi; Rangappa, Kanchuragoppal S; Ma, Lan; Zhu, Tao; Kumar, Alan Prem ; Huang, Ruby Yun-Ju ; Pandey, Vijay; Basappa; Lobie, Peter E
624-Mar-2022PI3K/AKT Signaling Tips the Balance of Cytoskeletal Forces for Cancer ProgressionDeng, Shuo ; Leong, Hin Chong ; Datta, Arpita ; Gopal, Vennila; Kumar, Alan Prem ; Yap, Celestial T 
717-Feb-2021Plasma osteopontin as a biomarker of Alzheimer's disease and vascular cognitive impairmentChai, Yuek Ling ; Chong, Joyce R ; Raquib, Ainiah R ; Xu, Xin ; Hilal, Saima ; Venketasubramanian, Narayanaswamy; Tan, Boon Yeow ; Kumar, Alan P ; Sethi, Gautam ; Chen, Christopher P ; Lai, Mitchell KP 
81-Dec-2021Pre-Clinical and Clinical Applications of Small Interfering RNAs (siRNA) and Co-Delivery Systems for Pancreatic Cancer TherapyMirzaei, Sepideh; Gholami, Mohammad Hossein; Ang, Hui Li; Hashemi, Farid; Zarrabi, Ali; Zabolian, Amirhossein; Hushmandi, Kiavash; Delfi, Masoud; Khan, Haroon; Ashrafizadeh, Milad; Sethi, Gautam ; Kumar, Alan Prem 
91-Jan-2021Putting the BRK on breast cancer: From molecular target to therapeuticsAng, Hui Li; Yuan, Yi ; Lai, Xianning ; Tan, Tuan Zea ; Wang, Lingzhi ; Huang, Benjamin BoJun; Pandey, Vijay; Huang, Ruby Yun-Ju; Lobie, Peter E ; Goh, Boon Cher ; Sethi, Gautam ; Yap, Celestial T ; Chan, Ching Wan ; Lee, Soo Chin ; Kumar, Alan Prem 
1015-Dec-2023SHP2 inhibitors maintain TGFβ signalling through SMURF2 inhibitionLai, Xianning ; Lui, Sarah Kit Leng ; Lam, Hiu Yan ; Adachi, Yuta; Sim, Wen Jing ; Vasilevski, Natali; Armstrong, Nicola J; Bridgeman, Stephanie Claire; Main, Nathan Michael; Tan, Tuan Zea ; Tirnitz-Parker, Janina EE; Thiery, Jean Paul ; Ebi, Hiromichi; Kumar, Alan Prem ; Eichhorn, Pieter Johan Adam 
1130-Mar-2021Super-enhancers for RUNX3 are required for cell proliferation in EBV-infected B cell linesHosoi, Hiroki ; Niibori-Nambu, Akiko; Nah, Giselle Sek Suan; Bahirvani, Avinash Govind ; Mok, Michelle Meng Huang ; Sanda, Takaomi ; Kumar, Alan Prem ; Tenen, Daniel G ; Ito, Yoshiaki; Sonoki, Takashi; Osato, Motomi 
1215-Apr-2019Targeting autophagy using natural compounds for cancer prevention and therapyDeng, Shuo ; Shanmugam, Muthu K ; Kumar, Alan Prem ; Yap, Celestial T ; Sethi, Gautam ; Bishayee, Anupam
131-May-2022Targeting Nuclear Receptors in Lung Cancer-Novel Therapeutic ProspectsGangwar, Shailendra Kumar; Kumar, Aviral; Yap, Kenneth Chun-Hong ; Jose, Sandra; Parama, Dey; Sethi, Gautam ; Kumar, Alan Prem ; Kunnumakkara, Ajaikumar B
142-Mar-2022The long and short non-coding RNAs modulating EZH2 signaling in cancerMirzaei, Sepideh; Gholami, Mohammad Hossein; Hushmandi, Kiavash; Hshemi, Farid; Zabolian, Amirhossein; Canadas, Israel; Zarrabi, Ali; Nabavi, Noushin; Aref, Amir Reza; Crea, Francesco; Wang, Yuzhuo; Ashrafizadeh, Milad; Kumar, Alan Prem 
154-Dec-2018Thymoquinone Inhibits Bone Metastasis of Breast Cancer Cells Through Abrogation of the CXCR4 Signaling AxisShanmugam, Muthu K ; Ahn, Kwang Seok; Hsu, Annie ; Woo, Chern Chiuh; Yuan, Yi; Tan, Kwong Huat Benny ; Chinnathambi, Arunachalam; Alahmadi, Tahani Awad; Alharbi, Sulaiman Ali; Koh, Angele Pei Fern; Arfuso, Frank; Huang, Ruby Yun-Ju; Lim, Lina HK ; Alan, Gautam Sethi ; Kumar, Alan Prem